-
Novartis Steals New Oncology Head From Pfizer
biospace
January 12, 2018
Novartis has got its new chief of oncology.
-
Bayer, Loxo Oncology to Develop, Commercialize Therapies for Genetic Drivers of Cancer
americanpharmaceuticacreview
November 15, 2017
Bayer has entered into an exclusive global collaboration with Loxo Oncology for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195.
-
With Kite in the bag, Gilead boosts oncology chief Riva to the head table
fiercepharma
October 18, 2017
Riva’s new job comes with a seat on Gilead’s top leadership team, and it puts him in charge of all of Gilead’s oncology programs, including cell therapy R&D.
-
Elligo is awarded evaluation of FDA-led project on harmonised data models for oncology treatment
pharmaasia
October 11, 2017
With a focus on oncology treatment data, the FDA is attempting to harmonise various data models which Elligo will test using electronic health records.
-
Merck, Project Data Sphere to pioneer Global Oncology Big Data Alliance
pharmaasia
September 14, 2017
Merck and Project Data Sphere big data platform to help accelerate innovative discovery, development and delivery of new approaches in cancer care.
-
Merck 'Grant for Oncology Innovation' Awards Recognize Recipients for Pushing Boundaries in Oncology
prnasia
September 11, 2017
Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Oncology Innovation (GOI) awards.
-
Amid dwindling cash and a Nasdaq warning, MabVax seeks ‘strategic options’
fiercebiotech
August 24, 2017
This comes as it overspent on a clinical trial
-
PAREXEL, Osaka International Cancer Institute form alliance to advance clinical research
pharmaasia
August 24, 2017
Alliance to drive greater efficiencies across clinical trials in oncology and haematology.
-
Takeda Allies with Austin for 'double whammy' cancer immunotherapies
fiercebiotech
August 14, 2017
The deal adds to a long list of alliances between Takeda and small biotechs.
-
Takeda reveals collaboration aimed at bolstering oncology pipeline
pharmafile
August 09, 2017
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move to prepare for this after signing a licensing collaboration with Molecular Templates.